Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.

van der Wilk BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, Nieuwenhuijzen GAP, Sosef MN, van Berge Henegouwen MI, Lagarde SM, Spaander MCW, Valkema R, Biermann K, Wijnhoven BPL, van der Gaast A, van Lanschot JJB, Doukas M, Nikkessen S, Luyer M, Schoon EJ, Roef MJ, van Lijnschoten I, Oostenbrug LE, Riedl RG, Gisbertz SS, Krishnadath KK, Bennink RJ, Meijer SL; Collaborators:.

Ann Surg. 2019 Oct 4. doi: 10.1097/SLA.0000000000003636. [Epub ahead of print]

PMID:
31592898
2.

Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study.

Hagens ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, van der Peet DL, Heisterkamp J, Nieuwenhuijzen GAP, Rosman C, Scheepers JJG, Sosef MN, van Hillegersberg R, Lagarde SM, Nilsson M, Räsänen J, Nafteux P, Pattyn P, Hölscher AH, Schröder W, Schneider PM, Mariette C, Castoro C, Bonavina L, Rosati R, de Manzoni G, Mattioli S, Garcia JR, Pera M, Griffin M, Wilkerson P, Chaudry MA, Sgromo B, Tucker O, Cheong E, Moorthy K, Walsh TN, Reynolds J, Tachimori Y, Inoue H, Matsubara H, Kosugi SI, Chen H, Law SYK, Pramesh CS, Puntambekar SP, Murthy S, Linden P, Hofstetter WL, Kuppusamy MK, Shen KR, Darling GE, Sabino FD, Grimminger PP, Meijer SL, Bergman JJGHM, Hulshof MCCM, van Laarhoven HWM, Mearadji B, Bennink RJ, Annema JT, Dijkgraaf MGW, Gisbertz SS.

BMC Cancer. 2019 Jul 4;19(1):662. doi: 10.1186/s12885-019-5761-7.

3.

Chemoradiation induces epithelial-to-mesenchymal transition in esophageal adenocarcinoma.

Steins A, Ebbing EA, Creemers A, van der Zalm AP, Jibodh RA, Waasdorp C, Meijer SL, van Delden OM, Krishnadath KK, Hulshof MCCM, Bennink RJ, Punt CJA, Medema JP, Bijlsma MF, van Laarhoven HWM.

Int J Cancer. 2019 Nov 15;145(10):2792-2803. doi: 10.1002/ijc.32364. Epub 2019 May 7.

4.

Quantitative assessment of liver function using hepatobiliary scintigraphy: the effect of microcirculatory alterations after portal vein embolization.

Rassam F, Uz Z, van Lienden KP, Ince C, Bennink RJ, van Gulik TM.

Nucl Med Commun. 2019 Jul;40(7):720-726. doi: 10.1097/MNM.0000000000001012.

PMID:
30998613
5.

A Pilot Study on Hepatobiliary Scintigraphy to Monitor Regional Liver Function in 90Y Radioembolization.

van der Velden S, Braat MNGJA, Labeur TA, Scholten MV, van Delden OM, Bennink RJ, de Jong HWAM, Lam MGEH.

J Nucl Med. 2019 Oct;60(10):1430-1436. doi: 10.2967/jnumed.118.224394. Epub 2019 Apr 6.

PMID:
30954942
6.

Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.

Buisman FE, Homs MYV, Grünhagen DJ, Filipe WF, Bennink RJ, Besselink MGH, Borel Rinkes IHM, Bruijnen RCG, Cercek A, D'Angelica MI, van Delden OM, Donswijk ML, van Doorn L, Doornebosch PG, Emmering J, Erdmann JI, IJzerman NS, Grootscholten C, Hagendoorn J, Kemeny NE, Kingham TP, Klompenhouwer EG, Kok NFM, Koolen S, Kuhlmann KFD, Kuiper MC, Lam MGE, Mathijssen RHJ, Moelker A, Oomen-de Hoop E, Punt CJA, Te Riele WW, Roodhart JML, Swijnenburg RJ, Prevoo W, Tanis PJ, Vermaas M, Versleijen MWJ, Veuger FP, Weterman MJ, Verhoef C, Groot Koerkamp B.

BMC Cancer. 2019 Apr 5;19(1):327. doi: 10.1186/s12885-019-5515-6.

7.

Accuracy of 18F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.

Valkema MJ, Noordman BJ, Wijnhoven BPL, Spaander MCW, Biermann K, Lagarde SM, Bennink RJ, Schreurs WMJ, Roef MJ, Hobbelink MGG, Janssen MJR, Graven LH, van Lanschot JJB, Valkema R.

J Nucl Med. 2019 Nov;60(11):1553-1559. doi: 10.2967/jnumed.118.224196. Epub 2019 Mar 15.

PMID:
30877177
8.

Comparison between dynamic gadoxetate-enhanced MRI and 99mTc-mebrofenin hepatobiliary scintigraphy with SPECT for quantitative assessment of liver function.

Rassam F, Zhang T, Cieslak KP, Lavini C, Stoker J, Bennink RJ, van Gulik TM, van Vliet LJ, Runge JH, Vos FM.

Eur Radiol. 2019 Sep;29(9):5063-5072. doi: 10.1007/s00330-019-06029-7. Epub 2019 Feb 22.

9.

Stress test of liver function using technetium-99m-mebrofenin hepatobiliary scintigraphy.

Rassam F, Cieslak KP, Beuers UHW, van Gulik TM, Bennink RJ.

Nucl Med Commun. 2019 Apr;40(4):388-392. doi: 10.1097/MNM.0000000000000979.

PMID:
30676547
10.

Practical guidelines for the use of technetium-99m mebrofenin hepatobiliary scintigraphy in the quantitative assessment of liver function.

Rassam F, Olthof PB, Richardson H, van Gulik TM, Bennink RJ.

Nucl Med Commun. 2019 Apr;40(4):297-307. doi: 10.1097/MNM.0000000000000973. Review.

PMID:
30601245
11.

Functional and volumetric assessment of liver segments after portal vein embolization: Differences in hypertrophy response.

Rassam F, Olthof PB, van Lienden KP, Bennink RJ, Besselink MG, Busch OR, van Gulik TM.

Surgery. 2019 Apr;165(4):686-695. doi: 10.1016/j.surg.2018.11.004. Epub 2018 Dec 17.

PMID:
30573191
12.

The role of proportionate kinetic growth rate fraction in future remnant liver function over volume determined by 99mTc-Mebrofenin hepatobiliary scintigraphy including SPECT and computed tomography in the risk prediction of postoperative mortality in ALPPS.

Lam HD, van der Pas SL, Baranski A, van Hoek B, Burgmans MC, Bennink RJ, de Geus-Oei LF.

Surgery. 2019 Jun;165(6):1244-1245. doi: 10.1016/j.surg.2018.10.020. Epub 2018 Nov 19. No abstract available.

PMID:
30467041
13.

Scintigraphic liver function and transient elastography in the assessment of patients with resectable hepatocellular carcinoma.

Rassam F, Olthof PB, Takkenberg BR, Beuers U, Klümpen HJ, Bennink RJ, van Lienden KP, Besselink MG, Busch OR, Verheij J, van Gulik TM.

HPB (Oxford). 2019 May;21(5):626-635. doi: 10.1016/j.hpb.2018.09.021. Epub 2018 Oct 23.

PMID:
30366883
14.

Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.

Borggreve AS, Mook S, Verheij M, Mul VEM, Bergman JJ, Bartels-Rutten A, Ter Beek LC, Beets-Tan RGH, Bennink RJ, van Berge Henegouwen MI, Brosens LAA, Defize IL, van Dieren JM, Dijkstra H, van Hillegersberg R, Hulshof MC, van Laarhoven HWM, Lam MGEH, van Lier ALHMW, Muijs CT, Nagengast WB, Nederveen AJ, Noordzij W, Plukker JTM, van Rossum PSN, Ruurda JP, van Sandick JW, Weusten BLAM, Voncken FEM, Yakar D, Meijer GJ; PRIDE study group.

BMC Cancer. 2018 Oct 20;18(1):1006. doi: 10.1186/s12885-018-4892-6.

15.

Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience.

Rassam F, Roos E, van Lienden KP, van Hooft JE, Klümpen HJ, van Tienhoven G, Bennink RJ, Engelbrecht MR, Schoorlemmer A, Beuers UHW, Verheij J, Besselink MG, Busch OR, van Gulik TM.

Langenbecks Arch Surg. 2018 May;403(3):289-307. doi: 10.1007/s00423-018-1649-2. Epub 2018 Jan 19. Review.

16.

Current Modalities for the Assessment of Future Remnant Liver Function.

Rassam F, Olthof PB, Bennink RJ, van Gulik TM.

Visc Med. 2017 Dec;33(6):442-448. doi: 10.1159/000480385. Epub 2017 Nov 30. Review.

17.

Liver related complications in unresectable disease after portal vein embolization.

Huisman F, Cieslak KP, van Lienden KP, Bennink RJ, van Gulik TM.

Hepatobiliary Surg Nutr. 2017 Dec;6(6):379-386. doi: 10.21037/hbsn.2017.02.03.

18.

Pilot-study on the feasibility of sentinel node navigation surgery in combination with thoracolaparoscopic lymphadenectomy without esophagectomy in early esophageal adenocarcinoma patients.

Künzli HT, van Berge Henegouwen MI, Gisbertz SS, van Esser S, Meijer SL, Bennink RJ, Wiezer MJ, Seldenrijk CA, Bergman JJGHM, Weusten BLAM.

Dis Esophagus. 2017 Nov 1;30(11):1-8. doi: 10.1093/dote/dox097.

PMID:
28881907
19.

Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function.

Olthof PB, Tomassini F, Huespe PE, Truant S, Pruvot FR, Troisi RI, Castro C, Schadde E, Axelsson R, Sparrelid E, Bennink RJ, Adam R, van Gulik TM, de Santibanes E.

Surgery. 2017 Oct;162(4):775-783. doi: 10.1016/j.surg.2017.05.022. Epub 2017 Jul 18.

PMID:
28732555
20.

99mTc-mebrofenin hepatobiliary scintigraphy predicts liver failure following major liver resection for perihilar cholangiocarcinoma.

Olthof PB, Coelen RJS, Bennink RJ, Heger M, Lam MF, Besselink MG, Busch OR, van Lienden KP, van Gulik TM.

HPB (Oxford). 2017 Oct;19(10):850-858. doi: 10.1016/j.hpb.2017.05.007. Epub 2017 Jul 4.

21.

Integrated Residency in Radiology and Nuclear Medicine in The Netherlands.

van Schaik JPJ, Bennink RJ.

J Nucl Med. 2017 Jul;58(7):9N-11N. No abstract available.

22.

The HIBA Index for ALPPS, Preliminary Results to Interpret With Caution.

Olthof PB, van Gulik TM, Bennink RJ.

Ann Surg. 2018 May;267(5):e97-e98. doi: 10.1097/SLA.0000000000002263. No abstract available.

PMID:
28426480
23.

Future remnant liver function as predictive factor for the hypertrophy response after portal vein embolization.

Cieslak KP, Huisman F, Bais T, Bennink RJ, van Lienden KP, Verheij J, Besselink MG, Busch ORC, van Gulik TM.

Surgery. 2017 Jul;162(1):37-47. doi: 10.1016/j.surg.2016.12.031. Epub 2017 Mar 30.

PMID:
28365007
24.

Hypothermic perfusion with retrograde outflow during right hepatectomy is safe and feasible.

Reiniers MJ, Olthof PB, van Golen RF, Heger M, van Beek AA, Meijer B, Leen R, van Kuilenburg ABP, Mearadji B, Bennink RJ, Verheij J, van Gulik TM.

Surgery. 2017 Jul;162(1):48-58. doi: 10.1016/j.surg.2017.01.024. Epub 2017 Mar 24.

PMID:
28343696
25.

Effect of obeticholic acid on liver regeneration following portal vein embolization in an experimental model.

Olthof PB, Huisman F, Schaap FG, van Lienden KP, Bennink RJ, van Golen RF, Heger M, Verheij J, Jansen PL, Olde Damink SW, van Gulik TM.

Br J Surg. 2017 Apr;104(5):590-599. doi: 10.1002/bjs.10466. Epub 2017 Feb 13.

PMID:
28195307
26.

Hepatic parenchymal transection increases liver volume but not function after portal vein embolization in rabbits.

Olthof PB, Schadde E, van Lienden KP, Heger M, de Bruin K, Verheij J, Bennink RJ, van Gulik TM.

Surgery. 2017 Oct;162(4):732-741. doi: 10.1016/j.surg.2016.12.014. Epub 2017 Feb 4.

PMID:
28173999
27.

Warm ischemia time-dependent variation in liver damage, inflammation, and function in hepatic ischemia/reperfusion injury.

Olthof PB, van Golen RF, Meijer B, van Beek AA, Bennink RJ, Verheij J, van Gulik TM, Heger M.

Biochim Biophys Acta Mol Basis Dis. 2017 Feb;1863(2):375-385. doi: 10.1016/j.bbadis.2016.10.022. Epub 2016 Oct 27.

28.

Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities.

Hens B, Corsetti M, Spiller R, Marciani L, Vanuytsel T, Tack J, Talattof A, Amidon GL, Koziolek M, Weitschies W, Wilson CG, Bennink RJ, Brouwers J, Augustijns P.

Int J Pharm. 2017 Mar 15;519(1-2):79-97. doi: 10.1016/j.ijpharm.2016.11.063. Epub 2016 Nov 30. Review.

PMID:
27915009
29.

Impact of Organic Cation Transporters (OCT-SLC22A) on Differential Diagnosis of Intrahepatic Lesions.

Visentin M, van Rosmalen BV, Hiller C, Bieze M, Hofstetter L, Verheij J, Kullak-Ublick GA, Koepsell H, Phoa SS, Tamai I, Bennink RJ, van Gulik TM, Stieger B.

Drug Metab Dispos. 2017 Feb;45(2):166-173. doi: 10.1124/dmd.116.072371. Epub 2016 Nov 30.

PMID:
27903597
30.

Comparable liver function and volume increase after portal vein embolization in rabbits and humans.

Olthof PB, Heger M, van Lienden KP, de Bruin K, Bennink RJ, van Gulik TM.

Surgery. 2017 Mar;161(3):658-665. doi: 10.1016/j.surg.2016.08.039. Epub 2016 Oct 18.

PMID:
27769661
31.

Measurement of liver function using hepatobiliary scintigraphy improves risk assessment in patients undergoing major liver resection.

Cieslak KP, Bennink RJ, de Graaf W, van Lienden KP, Besselink MG, Busch OR, Gouma DJ, van Gulik TM.

HPB (Oxford). 2016 Sep;18(9):773-80. doi: 10.1016/j.hpb.2016.06.006. Epub 2016 Jul 25.

32.

Optimal use of hepatobiliary scintigraphy before liver resection.

Olthof PB, van Gulik TM, Bennink RJ.

HPB (Oxford). 2016 Oct;18(10):870. doi: 10.1016/j.hpb.2016.06.008. Epub 2016 Jul 4. No abstract available.

33.

Liver function declines with increased age.

Cieslak KP, Baur O, Verheij J, Bennink RJ, van Gulik TM.

HPB (Oxford). 2016 Aug;18(8):691-6. doi: 10.1016/j.hpb.2016.05.011. Epub 2016 Jun 20.

34.

Distribution of lymph node metastases on FDG-PET/CT in inoperable or unresectable oesophageal cancer patients and the impact on target volume definition in radiation therapy.

Machiels M, Wouterse SJ, Geijsen ED, van Os RM, Bennink RJ, van Laarhoven HW, Hulshof MC.

J Med Imaging Radiat Oncol. 2016 Aug;60(4):520-7. doi: 10.1111/1754-9485.12474. Epub 2016 May 20.

PMID:
27197751
35.

The influence of somatostatin receptor scintigraphy during preoperative staging of non-functioning pancreatic neuroendocrine tumours.

Jilesen AP, Hoefnagel SJ, Busch OR, Bennink RJ, Gouma DJ, Nieveen van Dijkum EJ.

Clin Radiol. 2016 Jun;71(6):537-42. doi: 10.1016/j.crad.2016.01.015. Epub 2016 Mar 23.

PMID:
27016111
36.

Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.

Brandse JF, Bennink RJ, van Eeden S, Löwenberg M, van den Brink GR, DʼHaens GR.

Inflamm Bowel Dis. 2016 Jun;22(6):1384-90. doi: 10.1097/MIB.0000000000000746.

PMID:
26978724
37.

Assessment of Liver Function Using (99m)Tc-Mebrofenin Hepatobiliary Scintigraphy in ALPPS (Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy).

Cieslak KP, Olthof PB, van Lienden KP, Besselink MG, Busch OR, van Gulik TM, Bennink RJ.

Case Rep Gastroenterol. 2015 Nov 12;9(3):353-60. doi: 10.1159/000441385. eCollection 2015 Sep-Dec.

38.

18F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making.

Anderegg MC, de Groof EJ, Gisbertz SS, Bennink RJ, Lagarde SM, Klinkenbijl JH, Dijkgraaf MG, Bergman JJ, Hulshof MC, van Laarhoven HW, van Berge Henegouwen MI.

PLoS One. 2015 Nov 3;10(11):e0133690. doi: 10.1371/journal.pone.0133690. eCollection 2015.

39.

Intraoperative Fluid Restriction in Pancreatic Surgery: A Double Blinded Randomised Controlled Trial.

van Samkar G, Eshuis WJ, Bennink RJ, van Gulik TM, Dijkgraaf MG, Preckel B, de Hert S, Gouma DJ, Hollmann MW, Busch OR.

PLoS One. 2015 Oct 14;10(10):e0140294. doi: 10.1371/journal.pone.0140294. eCollection 2015.

40.

Functional hepatocellular regeneration measured by hepatobiliary scintigraphy, functional regeneration or functional hepatocytes?

Olthof PB, Cieslak KP, Bennink RJ, van Gulik TM.

Liver Int. 2016 Mar;36(3):463. doi: 10.1111/liv.12973. Epub 2015 Oct 15. No abstract available.

PMID:
26414913
41.

Prediction of postoperative liver failure in patients diagnosed with hepatocellular carcinoma using (99m)Tc-GSA SPECT/CT.

Cieslak KP, Bennink RJ, van Gulik TM.

Hepatobiliary Surg Nutr. 2015 Jun;4(3):203-5. doi: 10.3978/j.issn.2304-3881.2014.12.07. No abstract available.

42.

Gastric emptying and quality of life after pancreatoduodenectomy with retrocolic or antecolic gastroenteric anastomosis.

Eshuis WJ, de Bree K, Sprangers MA, Bennink RJ, van Gulik TM, Busch OR, Gouma DJ.

Br J Surg. 2015 Aug;102(9):1123-32. doi: 10.1002/bjs.9812. Epub 2015 Jun 18.

PMID:
26086157
43.

Feasibility and repeatability of PET with the hypoxia tracer [(18)F]HX4 in oesophageal and pancreatic cancer.

Klaassen R, Bennink RJ, van Tienhoven G, Bijlsma MF, Besselink MG, van Berge Henegouwen MI, Wilmink JW, Nederveen AJ, Windhorst AD, Hulshof MC, van Laarhoven HW.

Radiother Oncol. 2015 Jul;116(1):94-9. doi: 10.1016/j.radonc.2015.05.009. Epub 2015 Jun 3.

44.

The predictive value of C-reactive protein and erythrocyte sedimentation rate for 18F-FDG PET/CT outcome in patients with fever and inflammation of unknown origin.

Balink H, Veeger NJ, Bennink RJ, Slart RH, Holleman F, van Eck-Smit BL, Verberne HJ.

Nucl Med Commun. 2015 Jun;36(6):604-9. doi: 10.1097/MNM.0000000000000300.

PMID:
25738560
45.

¹⁸F-FDG PET/CT in inflammation of unknown origin: a cost-effectiveness pilot-study.

Balink H, Tan SS, Veeger NJ, Holleman F, van Eck-Smit BL, Bennink RJ, Verberne HJ.

Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1408-13. doi: 10.1007/s00259-015-3010-0. Epub 2015 Feb 6.

PMID:
25655485
46.

The role of 18F-FDG PET/CT in large-vessel vasculitis: appropriateness of current classification criteria?

Balink H, Bennink RJ, van Eck-Smit BL, Verberne HJ.

Biomed Res Int. 2014;2014:687608. doi: 10.1155/2014/687608. Epub 2014 Aug 14. Review.

47.

New perspectives in the assessment of future remnant liver.

Cieslak KP, Runge JH, Heger M, Stoker J, Bennink RJ, van Gulik TM.

Dig Surg. 2014;31(4-5):255-68. doi: 10.1159/000364836. Epub 2014 Oct 14. Review.

48.

In vivo imaging of enhanced leukocyte accumulation in atherosclerotic lesions in humans.

van der Valk FM, Kroon J, Potters WV, Thurlings RM, Bennink RJ, Verberne HJ, Nederveen AJ, Nieuwdorp M, Mulder WJ, Fayad ZA, van Buul JD, Stroes ES.

J Am Coll Cardiol. 2014 Sep 9;64(10):1019-29. doi: 10.1016/j.jacc.2014.06.1171.

49.

Monitoring of Total and Regional Liver Function after SIRT.

Bennink RJ, Cieslak KP, van Delden OM, van Lienden KP, Klümpen HJ, Jansen PL, van Gulik TM.

Front Oncol. 2014 Jun 16;4:152. doi: 10.3389/fonc.2014.00152. eCollection 2014.

50.

Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects.

Kessing BF, Smout AJ, Bennink RJ, Kraaijpoel N, Oors JM, Bredenoord AJ.

Neurogastroenterol Motil. 2014 Aug;26(8):1079-86. doi: 10.1111/nmo.12359. Epub 2014 May 29.

PMID:
24891067

Supplemental Content

Loading ...
Support Center